Cited by

• Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.

  Sabino EC, Lee TH, Montalvo L, Nguyen ML, Leiby DA, Carrick DM, Otani MM, Vinelli E, Wright D, Stramer SL, Busch M; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II) International Program. Sabino EC, et al. Transfusion. 2013 Jun;53(6):1257-65. doi: 10.1111/j.1537-2995.2012.03902.x. Epub 2012 Sep 25. Transfusion. 2013. PMID: 23002996 Free PMC article.
• The emergence of chagas disease in the United States and Canada.

  Kirchhoff LV, Pearson RD. Kirchhoff LV, et al. Curr Infect Dis Rep. 2007 Sep;9(5):347-50. doi: 10.1007/s11908-007-0053-9. Curr Infect Dis Rep. 2007. PMID: 17880844 No abstract available.
• Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi.

  Burns JM Jr, Shreffler WG, Rosman DE, Sleath PR, March CJ, Reed SG. Burns JM Jr, et al. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1239-43. doi: 10.1073/pnas.89.4.1239. Proc Natl Acad Sci U S A. 1992. PMID: 1371355 Free PMC article.
• Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.

  Kirchhoff LV, Votava JR, Ochs DE, Moser DR. Kirchhoff LV, et al. J Clin Microbiol. 1996 May;34(5):1171-5. doi: 10.1128/jcm.34.5.1171-1175.1996. J Clin Microbiol. 1996. PMID: 8727897 Free PMC article.
• Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study.

  Daltro RT, Santos EF, Silva ÂAO, Maron Freitas NE, Leony LM, Vasconcelos LCM, Luquetti AO, Celedon PAF, Zanchin NIT, Regis-Silva CG, Santos FLN. Daltro RT, et al. PLoS Negl Trop Dis. 2022 Nov 28;16(11):e0010944. doi: 10.1371/journal.pntd.0010944. eCollection 2022 Nov. PLoS Negl Trop Dis. 2022. PMID: 36441769 Free PMC article.